| Literature DB >> 21030245 |
Joshawna K Nunnery1, Emily Mevers, William H Gerwick.
Abstract
Marine cyanobacteria are a rich source of complex bioactive secondary metabolites which derive from mixed biosynthetic pathways. Recently, several marine cyanobacterial natural products have garnered much attention due to their intriguing structures and exciting anti-proliferative or cancer cell toxic activities. Several other recently discovered secondary metabolites exhibit insightful neurotoxic activities whereas others are showing pronounced anti-inflammatory activity. A number of anti-infective compounds displaying activity against neglected diseases have also been identified, which include viridamides A and B, gallinamide A, dragonamide E, and the almiramides.Entities:
Mesh:
Substances:
Year: 2010 PMID: 21030245 PMCID: PMC3034308 DOI: 10.1016/j.copbio.2010.09.019
Source DB: PubMed Journal: Curr Opin Biotechnol ISSN: 0958-1669 Impact factor: 9.740